Quent Capital, LLC Fulgent Genetics, Inc. Transaction History

Quent Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 14, 2024	BUY	$29.39 - $36.27 $1,939 - $2,393	66 New	66 $2,000
Q1 2023 Apr 05, 2023	BUY	$29.39 - $36.27 $29 - $36	1 Added 1.54%	66 $2,000
Q3 2022 Nov 10, 2022	SELL	$37.92 - $63.74 $37 - $63	-1 Reduced 1.52%	65 $3,000
Q2 2022 Aug 08, 2022	BUY	$47.98 - $62.75 $47 - $62	1 Added 1.54%	66 $4,000
Q4 2021 May 12, 2022	SELL	$77.3 - $105.0 $77 - $105	-1 Reduced 1.52%	65 $7,000
Q4 2021 Feb 28, 2022	BUY	$77.3 - $105.0 $5,101 - $6,930	66 New	66 $7,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Quent Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Quent Capital, LLC with notifications on news.